Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial

被引：0
|
作者：
Goette, Andreas
de Groot, Joris R.
Le Heuzey, Jean-Yves
Banach, Maciej
Huber, Kurt
Jin, James
Melino, Michael
Winters, Shannon M.
Themistoclakis, Sakis
Lip, Gregory
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Anticoagulants; Atrial fibrillation; Aging; Gender differences;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18190
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
    Giugliano, Robert P.
    Ruff, Christian T.
    Wiviott, Stephen D.
    Nordio, Francesco
    Murphy, Sabina A.
    Kappelhof, Johannes A. N.
    Shi, Minggao
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08): : 850 - +
  • [32] Edoxaban versus warfarin in atrial fibrillation patients with low, mid and high body weight: analysis of outcomes in the engage AF TIMI 48 trial
    Boriani, G.
    Ruff, C. T.
    Kuder, J. F.
    Shi, M.
    Lanz, H.
    Antman, E. M.
    Braunwald, E.
    Giugliano, R. P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 167 - 167
  • [33] Randomized Comparison of Progression of Atherosclerotic Plaques and Calcification of Coronary Artery in Atrial Fibrillation Patients Treated With Edoxaban Versus Warfarin (The REPRESENT-AF trial)
    Ahn, Jinhee
    Lee, Yoon Seong
    Lee, Whal
    Jeong, Baren
    Choi, Eue-Keun
    Shin, Dong Geum
    Han, Sang-Jin
    Lim, Hong Euy
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 229 : 56 - 62
  • [34] Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial
    Akashi, Shintaro
    Oguri, Mitsutoshi
    Ikeno, Eiichiro
    Manita, Mamoru
    Taura, Junki
    Watanabe, Saori
    Hayashi, Takuya
    Akao, Masaharu
    Okumura, Ken
    Akishita, Masahiro
    Yamashita, Takeshi
    JAMA NETWORK OPEN, 2022, 5 (08) : E2228500
  • [35] PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL
    Douketis, James
    Weitz, Jeffrey
    Murphy, Sabina
    Deenadayalu, Naveen
    Crompton, Andrea Elizabeth
    Mercuri, Michele
    Ruff, Christian
    Antman, Elliott
    Giugliano, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A2092 - A2092
  • [36] Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial
    Kuroda, Masaru
    Tamiya, Eiji
    Nose, Takahisa
    Ogimoto, Akiyoshi
    Taura, Junki
    Imamura, Yuki
    Fukuzawa, Masayuki
    Hayashi, Takuya
    Akao, Masaharu
    Yamashita, Takeshi
    Lip, Gregory Y. H.
    Okumura, Ken
    JAMA CARDIOLOGY, 2022, 7 (06) : 583 - 590
  • [37] Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
    Boriani, Giuseppe
    Ruff, Christian T.
    Kuder, Julia F.
    Shi, Minggao
    Lanz, Hans J.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (02) : 140 - 149
  • [38] Biphasic versus monophasic cardioversion in shock-resistant atrial fibrillation: A randomized clinical trial
    Khaykin, Y
    Newman, D
    Kowalewski, M
    Korley, V
    Dorian, P
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (08) : 868 - 872
  • [39] A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation
    Nin, Takamitsu
    Sairaku, Akinori
    Yoshida, Yukihiko
    Kamiya, Hiroki
    Tatematsu, Yasushi
    Nanasato, Mamoru
    Inden, Yasuya
    Hirayama, Haruo
    Murohara, Toyoaki
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (02): : 172 - 179
  • [40] Outcomes of rivaroxaban versus warfarin in women and men with nonvalvular atrial fibrillation: results from the ROCKET AF trial
    Dixon, B.
    Hellkamp, A. S.
    Lokhnygina, Y.
    Piccini, J. P.
    Berkowitz, S. D.
    Mahaffey, K. W.
    Becker, R. C.
    Breithardt, G.
    Fox, K. A. A.
    Patel, M. R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 744 - 744
12345